R&D Pipeline

Medeia has generated a robust discovery pipeline based on its scientists’ superior understanding and expertise in the molecular mechanisms of neurodegeneration and oncology. We intend to maintain several active R&D programs in the pipeline at all times.Each of the programs shown below consist of a series of potent molecules with potential to next generation back up products.

Click on the picture to enlarge R&D Pipeline

Download PDF

medeia_therapeutics_pipeline_2010.pdf